Informations sur le produit
Nom :
8-Hydroxy warfarin
Synonymes :
- 4,8-Dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one3-(a-Acetonylbenzyl)-4,8-dihydroxycoumarin
- 2,8-dihydroxy-3-(3-oxo-1-phenylbutyl)-4H-chromen-4-one
- 2H-1-Benzopyran-2-one, 4,8-dihydroxy-3-(3-oxo-1-phenylbutyl)-
- 3-(Alpha-Acetonylbenzyl)-4,8-Dihydrocoumarin
- 3-(Α-Acetonylbenzyl)-4,8-Dihydrocoumarin
- 3-(α-Acetonylbenzyl)-4,8-dihydrocoumarin, 4-8-Dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
- 4,8-Dihydroxy-3-(3-Oxo-1-Phenylbutyl)-2H-1-Benzopyran-2-One
- 4,8-dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
- Coumarin, 3-(α-acetonylbenzyl)-4,8-dihydroxy-
Description :
8-Hydroxy warfarin is a drug that belongs to the group of anticoagulants. It is a hydroxylated derivative of warfarin. Warfarin inhibits the synthesis of vitamin K-dependent clotting factors and the activation of vitamin K-dependent proteins, which are necessary for blood coagulation. 8-Hydroxy warfarin is a more potent inhibitor than warfarin and also has stereoselective properties. The rate of metabolism and elimination half-life of 8-hydroxy warfarin are increased in rats compared with humans, possibly due to differences in cytochrome P450 enzymes. The clinical relevance of these findings has not been determined yet.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
324.33 g/mol
Formule :
C19H16O5
Degré de pureté :
Min. 95%
Couleur/Forme :
White/Off-White Solid
InChI :
InChI=1S/C19H16O5/c1-11(20)10-14(12-6-3-2-4-7-12)16-17(22)13-8-5-9-15(21)18(13)24-19(16)23/h2-9,14,21-22H,10H2,1H3
Code InChI :
InChIKey=BHBOXPNWDGYJNB-UHFFFAOYSA-N
SMILES :
CC(=O)CC(c1ccccc1)c1c(O)c2cccc(O)c2oc1=O
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
